Intercure's IPO

Intercure raised a round of funding on July 31, 2007. Investors include Public.

InterCure (TASE: INCR), is a medical device company provides an FDA-cleared, non-drug, non-invasive hypertension treatment device RESPeRATE. InterCure's "Device-Guided Breathing" technology aims to en…

Articles about Intercure's IPO: